Flen Health taps AGC Biologics to make enzymes for next — generation wound treatment
AGC Biologics won a contract from Flen Health to develop and manufacture recombinant lactoperoxidase and glucose oxidase for a next-generation wound treatment. Work will be led by the Heidelberg facility, covering process development, scale-up, and GMP production to support an IND filing and Phase II trials. Manufactur